Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Fuji
Federal Trade Commission
Baxter
QuintilesIMS
McKinsey
Express Scripts
Merck
Harvard Business School
Citi

Generated: August 17, 2017

DrugPatentWatch Database Preview

Strides Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has thirty-four approved drugs.

There are two tentative approvals on STRIDES PHARMA drugs.

Summary for Applicant: Strides Pharma

Patents:0
Tradenames:27
Ingredients:27
NDAs:34
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma
ACARBOSE
acarbose
TABLET;ORAL090912-002Jul 27, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides Pharma
MELOXICAM
meloxicam
TABLET;ORAL077928-002May 13, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides Pharma
PRAMIPEXOLE DIHYDROCHLORIDE
pramipexole dihydrochloride
TABLET;ORAL202702-005Jun 3, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides Pharma
IBUPROFEN
ibuprofen
TABLET;ORAL078329-002Feb 5, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Strides Pharma
HYDRALAZINE HYDROCHLORIDE
hydralazine hydrochloride
TABLET;ORAL200770-002May 3, 2013AARXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Fish and Richardson
US Army
Accenture
Mallinckrodt
Cerilliant
Colorcon
Federal Trade Commission
AstraZeneca
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot